Literature DB >> 28870956

Targeted Delivery of Cordycepin to Liver Cancer Cells Using Transferrin-conjugated Liposomes.

Y E Bi1, Yulin Zhou1, Mengqiao Wang1, Lianlian Li1, Robert J Lee2,3,4, Jing Xie1, Lesheng Teng2,4.   

Abstract

BACKGROUND/AIM: Cordycepin is an endogenous nucleoside with significant anticancer biological activity. The objective of this study was to develop targeted liposomes to improve solubility and biological activity of cordycepin.
MATERIALS AND METHODS: We established transferrin-conjugated liposomes to deliver cordycepin to liver cancer cells and evaluated the uptake and effect.
RESULTS: The liposomes were loaded with cordycepin. Their average size was 125.3 nm, with drug encapsulation efficiency of 65.3%. The liposomes had good colloidal stability and released cordycepin slowly. Liposomal cordycepin was shown to increase reactive oxygen species production and cause depolarization of the mitochondrial transmembrane in liver cancer cells. Cellular uptake of liposomal cordycepin was enhanced by conjugation to transferrin, that facilitated receptor-mediated endocytosis.
CONCLUSION: Transferrin-conjugated liposomes are effective as nanocarriers for cordycepin delivery to liver cancer cells. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cordycepin; cell uptake; cytotoxicity; liposomes; protamine

Mesh:

Substances:

Year:  2017        PMID: 28870956     DOI: 10.21873/anticanres.11944

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Cordycepin Nanoencapsulated in Poly(Lactic-Co-Glycolic Acid) Exhibits Better Cytotoxicity and Lower Hemotoxicity Than Free Drug.

Authors:  Gregory Marslin; Vinoth Khandelwal; Gregory Franklin
Journal:  Nanotechnol Sci Appl       Date:  2020-06-12

2.  Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress.

Authors:  Anhui Yang; Zhen Sun; Rui Liu; Xin Liu; Yue Zhang; Yulin Zhou; Ye Qiu; Xinrui Zhang
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

Review 3.  A Systematic Review of the Biological Effects of Cordycepin.

Authors:  Masar Radhi; Sadaf Ashraf; Steven Lawrence; Asta Arendt Tranholm; Peter Arthur David Wellham; Abdul Hafeez; Ammar Sabah Khamis; Robert Thomas; Daniel McWilliams; Cornelia Huiberdina de Moor
Journal:  Molecules       Date:  2021-09-28       Impact factor: 4.411

4.  In silico and in vitro design of cordycepin encapsulation in liposomes for colon cancer treatment.

Authors:  Wasinee Khuntawee; Rawiporn Amornloetwattana; Wanwipa Vongsangnak; Katawut Namdee; Teerapong Yata; Mikko Karttunen; Jirasak Wong-Ekkabut
Journal:  RSC Adv       Date:  2021-02-25       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.